NasdaqGM:ADMABiotechs
A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations
ADMA Biologics (ADMA) stock has been in focus after short seller Culper Research alleged channel stuffing related to ASCENIV, prompting multiple securities law firms to launch investigations and potential class action lawsuits.
See our latest analysis for ADMA Biologics.
At a share price of $8.41, ADMA’s recent trading reflects sharp swings, with a 1-day share price gain of 6.73% sitting against a 7-day decline of 17.95% and a 90-day fall of 48.34%. The 5-year total shareholder return remains...